Xiaolu Zhang
Tianjin, 301617, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Naoxintong capsule accelerates mitophagy in cerebral ischemia-reperfusion injury via TP53/PINK1/PRKN pathway based on network pharmacology analysis and experimental validation.
Journal: Journal of ethnopharmacology
Published: July 02, 2024
Glycolytic reprogramming in microglia: A potential therapeutic target for ischemic stroke.
Journal: Cellular signalling
Published: June 24, 2024
Astrocyte modulation in cerebral ischemia-reperfusion injury: A promising therapeutic strategy.
Journal: Experimental neurology
Published: January 25, 2024
Chrysin inhibits ferroptosis of cerebral ischemia/reperfusion injury via regulating HIF-1α/CP loop.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 17, 2024
Sodium Danshensu ameliorates cerebral ischemia/reperfusion injury by inhibiting CLIC4/NLRP3 inflammasome-mediated endothelial cell pyroptosis.
Journal: BioFactors (Oxford, England)
Published: March 18, 2023
Chrysin protects against cerebral ischemia-reperfusion injury in hippocampus via restraining oxidative stress and transition elements.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 23, 2023
Pharmacological therapy to cerebral ischemia-reperfusion injury: Focus on saponins.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 08, 2022
Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review).
Journal: International journal of molecular medicine
Published: February 25, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026